Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

Analyst Ratings

HC Wainwright & Co. Maintains Buy Rating for Vir Biotechnology: Here’s What You Need To Know

By Benzinga Insights

January 23, 1:00 PM

HC Wainwright & Co. has decided to maintain its Buy rating of Vir Biotechnology (NASDAQ:VIR) and lower its…

VIR

Biden To Ask Supreme Court To Allow Student Loan Debt Relief Program To Resume

By Benzinga Newsdesk

November 17, 5:28 PM

- CNBC

SLM

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

January 9, 2:42 PM

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.

ALBO

Analyst Ratings

The Latest Analyst Ratings For JELD-WEN Holding

By Benzinga Insights

February 15, 8:00 AM

During the last three months, 4 analysts shared their evaluations of JELD-WEN Holding (NYSE:JELD), revealing diverse outlooks from…

JELD

Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Related Posts

HC Wainwright & Co. Maintains Buy Rating for Vir Biotechnology: Here’s What You Need To Know

Biden To Ask Supreme Court To Allow Student Loan Debt Relief Program To Resume

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

The Latest Analyst Ratings For JELD-WEN Holding